It was once feared weight-loss drugs would crush demand for sleep apnoea products. ResMed's December quarter has shown very ...

Ozempic, Wegovy and similar medications can drive dramatic weight loss, but doctors warn they’re not lifestyle shortcuts—and ...

Fans are slamming Serena Williams for the 'problematic' Super Bowl ad she filmed for Ro. Read more at SheFinds.com.

Dividend investors are likely to find the stock's 6.7% yield attractive. That yield is the result of a 100% dividend payout ratio -- meaning the company devotes all its profit to the payments -- so ...

ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business ...

A scientific study suggests that weight loss drugs could reduce the risk of several cancers associated with obesity.

There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

Acute pancreatitis is a sudden inflammation of the pancreas, an organ located behind the stomach that plays a key role in digestion ...

A new study has shown West Virginia residents rank second in the nation for income spent on the GLP-1 drug Ozempic. Researchers have suggested a correlation between ...

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...